Rocket Doctor has entered into a reseller agreement with Remmie, Inc., maker of the Remmie 4, an FDA approved and Health Canada Medical Devices Establishment
Celltrion’s biosimilar portfolio continues to grow, expanding treatment options to reach more patients in Canada Celltrion announced that Health Canada has approved Stoboclo and Osenvelt (CT-P41), biosimilars
CytoSorbents Corporation, a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, provided a regulatory update on its
SubtleHD delivers breakthrough efficiency and image quality to address Canada’s urgent need for faster MRI access. Subtle Medical, a global leader in AI-powered medical imaging enhancement, announced
Cortechs.ai, a global leader in AI-driven medical imaging analysis, is proud to announce that that it has received approval from Health Canada for the sale
Test4D Serum is a qualitative test to detect Vitamin D levels in the blood. NanoSpeed Diagnostics Inc. is pleased to announce that Health Canada has
Catalyst Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, reported
Health Canada’s approval enables 4Moving Biotech to initiate the INFLAM MOTION Phase 2a clinical trial 4Moving Biotech , a spin-off of 4P-Pharma dedicated to developing
Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive,
